Hot Medical Stocks To Own For 2019

tags:SVVC,RAIL,REE,ESNC,TGTX,TEP,

By taking a risk in 2014 and building a company around a single manmade cannabinoid, drugmaker Corbus Pharmaceuticals is now ahead of its larger peers on a number of key treatments, CEO Yuval Cohen said Thursday.

"We are a tiny company, very nimble, but because we took the risk a number of years ago — whereas big pharma, remember, they're slower, they're more risk-averse — we're actually ahead of the pack," Cohen told CNBC in an interview with Jim Cramer.

Though cannabis has largely been seen as taboo by big pharma until recently, some of the larger names are waking up to the medical benefits its derivatives can provide.

Cohen specifically referenced a 2017 deal by Johnson & Johnson subsidiary Janssen Pharmaceuticals with clinical-stage biopharmaceutical company Bird Rock Bio to explore targeting cannabinoid receptors in the liver to treat NASH, or non-alcoholic steatohepatitis. On Tuesday, Tilray CEO Brendan Kennedy told Cramer his cannabis producer struck a deal with a division of Novartis.

Hot Medical Stocks To Own For 2019: Firsthand Technology Value Fund, Inc.(SVVC)

Advisors' Opinion:

• [By Max Byerly]

  Intl Fcstone Inc. increased its position in shares of Firsthand Technology Value Fund Inc (NASDAQ:SVVC) by 35.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 30,087 shares of the investment management company’s stock after acquiring an additional 7,924 shares during the period. Intl Fcstone Inc.’s holdings in Firsthand Technology Value Fund were worth $510,000 as of its most recent filing with the Securities and Exchange Commission.

Hot Medical Stocks To Own For 2019: Freightcar America, Inc.(RAIL)

Advisors' Opinion:

• [By Stephan Byrd]

  FreightCar America (NASDAQ:RAIL) Director Thomas A. Madden sold 7,506 shares of the firm’s stock in a transaction that occurred on Friday, May 18th. The stock was sold at an average price of $15.69, for a total value of $117,769.14. Following the completion of the sale, the director now owns 20,224 shares of the company’s stock, valued at approximately $317,314.56. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

• [By Ethan Ryder]

  Wells Fargo & Company MN increased its stake in FreightCar America, Inc. (NASDAQ:RAIL) by 95.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 730,734 shares of the transportation company’s stock after acquiring an additional 357,670 shares during the period. Wells Fargo & Company MN owned about 5.87% of FreightCar America worth $9,790,000 as of its most recent SEC filing.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on FreightCar America (RAIL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Lisa Levin]

  Friday afternoon, the industrial shares rose 0.64 percent. Meanwhile, top gainers in the sector included Deere & Company (NYSE: DE), up 7 percent, and FreightCar America, Inc. (NASDAQ: RAIL) up 6 percent.

• [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday. Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each. Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55. Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months. Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75. STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results. Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday. China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday. YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings. MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings. Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share. Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701. Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings. The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings. Ca

Hot Medical Stocks To Own For 2019: Rare Element Resources Ltd.(REE)

Advisors' Opinion:

• [By Logan Wallace]

  ReeCoin (CURRENCY:REE) traded flat against the dollar during the 1-day period ending at 14:00 PM Eastern on June 27th. Over the last week, ReeCoin has traded 5% higher against the dollar. One ReeCoin coin can now be purchased for about $0.0001 or 0.00000001 BTC on popular exchanges. ReeCoin has a total market cap of $175,206.00 and $0.00 worth of ReeCoin was traded on exchanges in the last day.

Hot Medical Stocks To Own For 2019: EnSync, Inc.(ESNC)

Advisors' Opinion:

• [By Logan Wallace]

  Get a free copy of the Zacks research report on EnSync (ESNC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Get a free copy of the Zacks research report on EnSync (ESNC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  EnSync (NYSEAMERICAN:ESNC) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, September 25th. Analysts expect EnSync to post earnings of ($0.05) per share for the quarter.

• [By Stephan Byrd]

  EnSync Inc (NYSEAMERICAN:ESNC) shares fell 17.6% during trading on Thursday . The stock traded as low as $0.26 and last traded at $0.28. 1,730,346 shares traded hands during mid-day trading, an increase of 503% from the average session volume of 286,820 shares. The stock had previously closed at $0.34.

• [By Money Morning Staff Reports]

  After looking at last week's top penny stocks, we'll show you this top penny stock…

  Penny Stock Sector Current Share Price Last Week's Gain Sky Solar Holdings Ltd. (NASDAQ: SKYS) Utilities $1.19 111.74% Zosano Pharma Corp. (NASDAQ: ZSAN) Healthcare $4.54 106.36% Achieve Life Sciences Inc. (NASDAQ: ACHV) Healthcare $3.30 89.66% EnSync Inc. (NYSE: ESNC) Industrial Goods $0.13 85.00% Riot Blockchain Inc. (NASDAQ: RIOT) Healthcare $3.95 74.78% Ideanomics Inc. (NASDAQ: IDEX) Technologies $1.97 71.30% Eco-Stim Energy Solutions Inc. (OTCMKTS: ESES) Basic Materials $0.27 54.65% Pier 1 Imports Inc. (NYSE: PIR) Services $1.31 47.91% Marathon Patent Group Inc. (NASDAQ: MARA) Services $0.74 42.29% China Internet NationWide Financial Services Inc. (NASDAQ: CIFS) Financial $1.28 42.24%

  As you can see, knowing where to look for the top penny stocks could reward you with double-digit, or even triple-digit, returns in mere days.

• [By Joseph Griffin]

  ZBB Energy (NYSEAMERICAN:ESNC) has been given a $2.00 price target by research analysts at HC Wainwright in a report released on Wednesday. The brokerage presently has a “buy” rating on the technology company’s stock. HC Wainwright’s target price suggests a potential upside of 471.43% from the stock’s current price.

Hot Medical Stocks To Own For 2019: TG Therapeutics, Inc.(TGTX)

Advisors' Opinion:

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on TG Therapeutics Inc common stock (TGTX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By George Budwell]

  Shares of the B-cell malignancy and autoimmune disease specialist TG Therapeutics (NASDAQ:TGTX) fell by an eye-popping 55.9% last month, according to data from S&P Global Market Intelligence. What triggered this dramatic sell-off?

• [By Logan Wallace]

  Get a free copy of the Zacks research report on TG Therapeutics Inc common stock (TGTX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Paul Ausick]

  TG Therapeutics Inc. (NASDAQ: TGTX) dropped about 40% Tuesday to set a new 52-week low of $5.50. Shares closed at $9.25 on Monday and the stock’s 52-week high is $17.35. Volume was about 70% higher than the daily average of around 7.4 million. The company said it is no longer considering an accelerated application for a clinical drug trial.

• [By Todd Campbell]

  Fueled by trial data, TG Therapeutics (NASDAQ:TGTX) shares skyrocketed 69.5% in February, according to S&P Global Market Intelligence.

  So what

  On Jan. 30, data from phase 1 trials evaluating TG Therapeutics' ublituximab and umbralisib alongside J&J and AbbVie's Imbruvica was published in Lancet, a respected industry journal. 

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on TG Therapeutics (TGTX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks To Own For 2019: Tallgrass Energy Partners, LP(TEP)

Advisors' Opinion:

• [By ]

  Cramer was bearish on Melco Resorts (MLCO) , Tallgrass Energy Partners (TEP) , Mallinckrodt (MNK) , Roku (ROKU) and Scotts Miracle-Gro (SMG) .

  Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Tallgrass Energy Partners (TEP)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Matthew DiLallo]

  Earlier this year, Tallgrass Energy GP (NYSE:TEGP) agreed to acquire its master limited partnership, Tallgrass Energy Partners (NYSE:TEP) in an all-stock deal. This transaction is one of many similar ones in the sector over the past few years as energy infrastructure companies have had to grapple with the fallout of the oil market downturn. Like the deals before it, and those announced afterward, the transaction will create one stronger entity that's well positioned to grow in the coming years while still offering income-seeking investors a generous income stream. That income with upside makes Tallgrass a stock that investors will want to keep on their radar, especially considering the strength of its financial profile.

• [By ]

  Tallgrass Energy Partners (TEP) : "That dividend is a red flag. That group has become a house of pain and I'm not going there."

  Mallinckrodt (MNK) : "They had a better-than-expected quarter, but I am worried and I'm staying away."

• [By Logan Wallace]

  Natixis bought a new position in Tallgrass Energy Partners LP (NYSE:TEP) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 68,685 shares of the pipeline company’s stock, valued at approximately $2,975,000. Natixis owned 0.09% of Tallgrass Energy Partners as of its most recent filing with the Securities & Exchange Commission.